News & Events

31 07, 2024

Shortening FDA-Mandated CAR T-Cell Therapy Monitoring Periods Could Improve Access to Treatment in Patients With DLBCL

2024-07-31T13:47:53+00:00

Two hallmark toxicities of chimeric antigen receptor (CAR) T-cell therapy may be rare after 2 weeks following infusion in patients with diffuse large B-cell lymphoma (DLBCL), supporting a shorter, more flexible toxicity monitoring period, according to a recent study...

Shortening FDA-Mandated CAR T-Cell Therapy Monitoring Periods Could Improve Access to Treatment in Patients With DLBCL2024-07-31T13:47:53+00:00
13 05, 2024

American Assoc. of Pharmaceutical Scientists (AAPS) National Biotechnology Conference – 2024

2025-03-14T18:59:26+00:00

Avance Biosciences™ offers top-tier GLP & GMP compliant services in assay development, validation, & sample testing for biopharma. Visit our booth to explore how we support drug discovery, development, & manufacturing with precision & expertise. [...]

American Assoc. of Pharmaceutical Scientists (AAPS) National Biotechnology Conference – 20242025-03-14T18:59:26+00:00
7 05, 2024

American Society of Gene and Cell Therapy (ASGCT) Conference – 2024

2025-03-14T19:17:52+00:00

Avance Biosciences™ is excited to announce our participation in the American Society of Gene & Cell Therapy (ASGCT) conference, where we’ll be showcasing our advanced services and expertise to propel the future of gene and cell therapy. [...]

American Society of Gene and Cell Therapy (ASGCT) Conference – 20242025-03-14T19:17:52+00:00
6 05, 2024

Workshops on Recent Issues in Bioanalysis (WRIB) Conference – 2024

2025-03-14T19:20:41+00:00

Ensure the Success of Your Biological Drug Development - Avance Provides Assays to Support your Biopharmaceutical Development & Manufacturing - Avance Biosciences™ is a world-leading CRO specializing in GLP & GMP compliant biological assay development, assay validation, and [...]

Workshops on Recent Issues in Bioanalysis (WRIB) Conference – 20242025-03-14T19:20:41+00:00
3 04, 2024

Stealing Strategies from Cancerous T Cells May Boost Immunotherapy

2024-07-13T13:07:32+00:00

CAR T-cell therapies show promise for blood cancers but struggle with solid tumors due to T-cell weakness in tumor microenvironments. Researchers find genetic alterations in cancerous T cells, giving engineered T cells "superpowers" to effectively kill tumors without behaving like cancer cells...

Stealing Strategies from Cancerous T Cells May Boost Immunotherapy2024-07-13T13:07:32+00:00
25 03, 2024

eGenesis Announces World’s First Successful Transplant of Genetically Engineered Porcine Kidney in a Living Patient

2024-07-10T19:42:20+00:00

In a groundbreaking development that could revolutionize organ transplantation, eGenesis, a biotechnology company dedicated to addressing the global organ shortage crisis, has announced the successful transplantation of a genetically engineered porcine kidney into a living human recipient...

eGenesis Announces World’s First Successful Transplant of Genetically Engineered Porcine Kidney in a Living Patient2024-07-10T19:42:20+00:00
14 03, 2024

qPCR or ddPCR for Bioanalysis? – Download our Comprehensive Guide

2025-02-21T14:25:22+00:00

This comprehensive guide explores the essential tools of quantitative PCR (qPCR) and digital droplet PCR (ddPCR) in the biopharmaceutical industry, offering invaluable insights into their applications, strengths, and limitations. Download now to stay ahead of the curve in pharmaceutical research and development...

qPCR or ddPCR for Bioanalysis? – Download our Comprehensive Guide2025-02-21T14:25:22+00:00
Go to Top